CHMP Recommends Approval of Opioid-Induced Constipation Drug

The European Medicines Agency’s committee recommended approval of the mu-opioid receptor antagonist for treatment of opioid-induced constipation in adults previously been treated with a laxative.
News Alerts

Source link

Related posts

Evaluating depression and suicidality in tetrabenazine users with Huntington disease


New Findings Could Make Mosquitoes More Satisfied, and Safer to Be Around


Pharmacotherapy of Cardiovascular Autonomic Dysfunction in Parkinson Disease.


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy